NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of metabolic reactions — energy production, DNA repair, sirtuin activation, and circadian rhythm regulation. NAD+ levels decline ~50% between age 20 and 60 in most tissues. This decline is associated with nearly every hallmark of aging: mitochondrial dysfunction, DNA damage accumulation, inflammation.
The NAD+ supplement market is built on one foundational question: can you raise tissue NAD+ levels by supplementing its precursors, and does doing so slow aging? The first part is answered. The second remains unresolved in humans.
NMN is one step closer to NAD+ in the biosynthesis pathway than NR. It was initially thought to be poorly absorbed because it's a larger molecule — this was the basis for early claims that NR was superior. A 2022 clinical study by Irie et al. showed that oral NMN reliably raises blood NAD+ metabolite levels, and a growing body of human trials confirms this.
What human NMN trials have shown: improved insulin sensitivity in overweight women (Washington University, 2021); improved muscle function in older adults (Keio University, 2022); improved aerobic capacity in recreational runners (2021). None of these are large RCTs, but the pattern is consistent.
NMN Supplements on Amazon →NR (sold as Tru Niagen / BASIS) has the most human clinical trial data of the three, largely because ChromaDex (which holds NR patents) has funded a large clinical research program. Multiple RCTs confirm NR raises blood NAD+ significantly — typically 40–90% increase over baseline at 300–1000mg/day doses.
What the human NR data shows: robust NAD+ raising (consistent across trials); modest improvements in blood pressure and arterial stiffness in older adults (University of Colorado, 2018); no significant effect on muscle function or exercise performance in most trials. The honest assessment: NR reliably raises NAD+, but the clinical endpoints that matter for longevity have been largely inconclusive in human trials to date.
NR (Tru Niagen) on Amazon →Oral NAD+ supplementation is essentially a waste of money. NAD+ is broken down in the gut before it can be absorbed — the molecular structure is too large and unstable for meaningful oral bioavailability. IV NAD+ infusions bypass this and do raise systemic NAD+, but at significant cost ($200–500/session) and with no RCT data supporting superior outcomes vs. oral NMN/NR. The wellness industry's oral NAD+ products are largely ineffective compared to precursor supplementation.
| Factor | NMN (500mg) | NR (300mg) |
|---|---|---|
| NAD+ raising (blood) | +40–60% over baseline | +40–90% over baseline |
| Human RCT count | 8–12 published | 20+ published |
| Proximity to NAD+ in pathway | One step | Two steps |
| Price/month (typical) | $40–80 | $40–60 |
| Tissue penetration evidence | Muscle (human RCT) | Blood (robust); tissue (limited) |
| Key advantage | Newer data; muscle evidence | More total research |
| TMG co-factor needed? | Yes (methyl donor) | Yes (methyl donor) |
Both NMN and NR are converted to NAD+ via a methylation pathway. This consumes methyl groups, potentially depleting SAM (S-adenosylmethionine) — the body's primary methyl donor used in hundreds of reactions including epigenetic regulation and neurotransmitter synthesis. The practical recommendation: supplement TMG (trimethylglycine / betaine) at 500mg alongside NMN or NR. It's cheap, well-tolerated, and covers the methyl group requirement without the cost of SAM-e.
TMG Supplement on Amazon → Build Full Stack at StackProtocol →NMN and NR work as NAD+ precursors — they raise blood NAD+ in humans. The mouse longevity data is genuinely compelling (lifespan extension, improved muscle function, better metabolic health). Whether this translates to human longevity outcomes is the critical unanswered question, and will likely remain unanswered for another decade given the trial timelines required.
If you supplement: NMN is the better choice for people focused on muscle and metabolic outcomes based on newer trial data. NR is the choice for those who prefer more established human trial history. Both are safe. Neither is cheap. The lifestyle interventions on this site — Zone 2 training, adequate sleep, resistance training — have substantially stronger human evidence for longevity outcomes than any NAD+ precursor currently does.
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.